Arax Advisory Partners’s Core Laboratories CLB Stock Holding History

Arax Advisory Partners’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$12.3K	Buy	1,052 +946	+892%	+$13.5K	﹤0.01%	4237
2026 Q1	$1.78K	Sell	106 -48	-31%	-$859	﹤0.01%	3136
2025 Q4	$2.47K	Sell	154 -578	-79%	-$8.6K	﹤0.01%	3187
2025 Q3	$9.05K	Buy	+732	New	+$8.58K	﹤0.01%	2642
2025 Q1	–	Sell	-165	Closed	-$2.86K	–	2733
2024 Q4	$2.86K	Hold	165	–	–	﹤0.01%	1921
2024 Q3	$3.06K	Buy	+165	New	+$3.31K	﹤0.01%	1911
2018 Q4	$43K	Sell	728 -27	-4%	-$2.33K	0.02%	287
2018 Q3	$87K	Buy	755 +28	+4%	+$3.16K	0.04%	218
2018 Q2	$91K	Buy	727 +368	+103%	+$44.8K	0.04%	168
2018 Q1	$38K	Sell	359 -95	-21%	-$10.5K	0.02%	226
2017 Q4	$49K	Sell	454 -2	-0.4%	-$200	0.02%	214
2017 Q3	$45K	Hold	456	–	–	0.02%	223
2017 Q2	$46K	Buy	456 +17	+4%	+$1.83K	0.02%	237
2017 Q1	$50K	Buy	439 +63	+17%	+$7.32K	0.02%	206
2016 Q4	$45K	Buy	+376	New	+$41.6K	0.02%	180

Other funds holding CLB

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Arax Advisory Partners's CLB Position: Q2 2026 in Review

Arax Advisory Partners increased its Core Laboratories (CLB) stake by 892% in Q2 2026, buying an estimated $13.5K and bringing the position to 1,052 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4237.

Arax Advisory Partners first reported a position in CLB in Q4 2016 and has held it in 15 quarters since. The position peaked at $91K in Q2 2018. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

Arax Advisory Partners held 1,052 shares of Core Laboratories worth $12.3K as of Q2 2026.
Arax Advisory Partners bought 946 Core Laboratories shares in Q2 2026, an estimated $13.5K.
Core Laboratories made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #4237 holding.
Arax Advisory Partners first reported a position in Core Laboratories in Q4 2016 and has held it in 15 quarters since.
Arax Advisory Partners's Core Laboratories position peaked at $91K in Q2 2018.
186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.